Search PubMedSearch

PubMed · 8768795

Antigen presentation--recent developments.

Abstract

Antigen presentation is principally a function of MHC molecules, assisted by a number of adhesion and co-stimulatory molecules not immediately involved in antigen handling. Each MHC molecule, class I or class II, presents peptides derived from self or foreign proteins according to individual rules which have been elucidated in detail for several dozens of MHC molecules. How such peptides are produced by the antigen processing devices in a cell is less well understood; for class I-restricted processing, proteasomes, TAP molecules and probably chaperones are key players whereas the invariant chain, DM molecules, and a number of proteins are central to class II loading. Currently of special interest are alternative class I-loading pathways, nonclassical MHC molecules, the way NK cells recognize their targets, and the use of MHC peptide specificities for applications in immune therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H G Rammensee. 1996. Antigen presentation--recent developments.. https://doi.org/10.1159/000237320

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Contribution of advances in immunology to vaccine development.

During the last 10 years, investigation of the bovine immune system has generated knowledge and reagents that can now be applied to study the mechanisms of immunity to disease and the identity of antigens recognized by protective immune responses. Such studies can indicate which antigens are likely to be effective in subunit vaccines and also highlight the type of antigen delivery system that will be required for a vaccine to induce a protective immune response. In the case of bovine RSV, studies of immune responses in the target host have demonstrated that both antibody and CTL responses play an important role in immunity. Both the F and G glycoproteins have been identified as targets of protective antibodies, and systems have been established that will allow the identification of the viral antigens recognized by CTL. Further studies of CD4+ T-cell responses to the virus are required to determine whether or not components of the response have the potential to enhance disease and, therefore, need to be avoided in vaccination strategies.

Allergy and Immunology